Gujarat Terce Laboratories
Gujarat Terce Laboratories Share Price Chart
Gujarat Terce Laboratories last traded at ₹42.99 (2026-10-13). Over the past month the stock moved +4.9%, three months the stock moved +24.0%, year the stock moved +5.4%. Its closing range over 52 weeks is ₹31.15 – ₹49.96, with the latest close 14.0% below the high.
Closing prices up to 2026-10-13.
About Gujarat Terce Laboratories
Incorporated in 1985. Gujarat Terce Laboratories Ltd is engaged in development, manufacturing, marketing and distribution of medicines, healthcare products and branded generics
Product Profile:[1] Company has an extensive basket of 50 Brands (125 products) with a portfolio contributing to 10 therapeutic areas, covering multiple dosage forms like Tablets, Capsules, Oral Liquids, Ointments and Injectables.
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Gujarat Terce Laboratories reported sales of ₹9.00 crore (-17.1%) and net profit of ₹-0.18 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 9.00 | -0.49 | -5.44 | -0.18 | -0.23 |
| Mar 2026 | 11.40 | 0.74 | 6.49 | 0.10 | 0.13 |
| Dec 2025 | 12.29 | 1.13 | 9.19 | 0.76 | 0.98 |
| Sep 2025 | 12.93 | 1.90 | 14.69 | 1.40 | 1.89 |
| Jun 2025 | 10.85 | -0.01 | -0.09 | -0.04 | -0.05 |
| Mar 2025 | 12.32 | 1.05 | 8.52 | -3.39 | -4.57 |
| Dec 2024 | 12.68 | 1.08 | 8.52 | 1.01 | 1.36 |
| Sep 2024 | 13.30 | 1.66 | 12.48 | 1.48 | 1.99 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +10.6% | -2.6% | +0.9% | -8.7% | -2.8% | -3.1% | -7.5% | -17.1% |
| Operating profit growth | +201.8% | +28.6% | +4.0% | -112.5% | +14.5% | +4.6% | -29.5% | – |
| Net profit growth | +348.5% | +50.7% | -727.8% | – | -5.4% | -24.8% | – | – |
| EPS growth | +352.3% | +51.1% | -726.0% | – | -5.0% | -27.9% | – | – |
| OPM % | 12.5% | 8.5% | 8.5% | -0.1% | 14.7% | 9.2% | 6.5% | -5.4% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Gujarat Terce Laboratories reported sales of ₹47.47 crore (-5.4%) and net profit of ₹2.20 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 47.47 | 3.75 | 7.90 | 2.20 | 2.82 |
| Mar 2025 | 50.20 | 3.89 | 7.75 | -0.98 | -1.32 |
| Mar 2024 | 47.92 | 1.27 | 2.65 | 0.24 | 0.32 |
| Mar 2023 | 46.78 | -2.16 | -4.62 | -1.67 | -2.25 |
| Mar 2022 | 40.13 | 1.11 | 2.77 | 0.87 | 1.17 |
| Mar 2021 | 25.18 | -2.59 | -10.29 | -2.52 | -3.40 |
| Mar 2020 | 37.54 | 0.68 | 1.81 | 0.28 | 0.38 |
| Mar 2019 | 31.03 | 0.49 | 1.58 | 0.43 | 0.58 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +7.0% | +21.0% | -32.9% | +59.4% | +16.6% | +2.4% | +4.8% | -5.4% |
| Operating profit growth | +48.5% | +38.8% | -480.9% | – | -294.6% | – | +206.3% | -3.6% |
| Net profit growth | +59.3% | -34.9% | -1000.0% | – | -292.0% | – | -508.3% | – |
| EPS growth | +61.1% | -34.5% | -994.7% | – | -292.3% | – | -512.5% | – |
| OPM % | 1.6% | 1.8% | -10.3% | 2.8% | -4.6% | 2.7% | 7.8% | 7.9% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Gujarat Terce Laboratories.
Get Free AI Stock Analysis FREE →Latest News
-
Gujarat Terce Labs. reports Profit after tax of Rs -1.77 Mln, in the June 2026 quarter
-
Gujarat Terce Laboratories Q1 Results: Net profit rises 12% YoY to ₹205 crore - scanx.trade
Frequently Asked Questions
What is the share price of Gujarat Terce Laboratories today?
Gujarat Terce Laboratories shares were last quoted at ₹42.99 (+18.8% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Gujarat Terce Laboratories?
Gujarat Terce Laboratories has a price-to-earnings (P/E) ratio of 13.87 and a price-to-book (P/B) ratio of 3.68. The industry P/E is 52.82.
What is the 52-week high and low of Gujarat Terce Laboratories?
The 52-week high of Gujarat Terce Laboratories is ₹59.78 and the 52-week low is ₹29.00.
What is the market cap of Gujarat Terce Laboratories?
The market capitalisation of Gujarat Terce Laboratories is about ₹28.92 crore.
How did Gujarat Terce Laboratories perform in its latest quarterly results?
In the latest quarter (Jun 2026), Gujarat Terce Laboratories reported sales of ₹9.00 crore (-17.1%) and net profit of ₹-0.18 crore, compared with the same quarter last year.
Is Gujarat Terce Laboratories a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Gujarat Terce Laboratories has a 3-year ROE of 8.00%, 3-year profit growth of 51.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Gujarat Terce Laboratories?
Promoters hold about 40.03% of Gujarat Terce Laboratories.
Which sector does Gujarat Terce Laboratories belong to?
Gujarat Terce Laboratories belongs to the Pharmaceuticals & Drugs sector.